
Current Price | $126.69 | Mkt Cap | $16.6B |
---|---|---|---|
Open | $126.91 | P/E Ratio | 11.91 |
Prev. Close | $126.69 | Div. (Yield) | $2.48 (2.0%) |
Daily Range | $125.69 - $127.30 | Volume | 1,062,163 |
52-Wk Range | $85.41 - $134.71 | Avg. Daily Vol. | 1,234,239 |
A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.
Current Price | $126.69 | Mkt Cap | $16.6B |
---|---|---|---|
Open | $126.91 | P/E Ratio | 11.91 |
Prev. Close | $126.69 | Div. (Yield) | $2.48 (2.0%) |
Daily Range | $125.69 - $127.30 | Volume | 1,062,163 |
52-Wk Range | $85.41 - $134.71 | Avg. Daily Vol. | 1,234,239 |
The best Bull and Bear pitches based on recency and number of recommendations.
Low p/e p/b and p/s with solid profits dividends and return of equity. It has quite a bit of debt (debt to equity of .8), but still has decent cash flow. No real growth.
Near-term reimbursement decreases from ACA and regular decreases in Medicare fee schedule. Theranos accepts 50% of the Medicare rate, and process is much more patient friendly; this is the real threat to DGX and LH.
Read the most recent pitches from players about DGX.
Recs
Dividends500 tracks the healthiest dividends in the S&P 500.
To qualify for the portfolio, the company must meet three simple requirements:
- Member of the S&P 500
- Payout ratio below 50%
- Dividend growth year over year
Recs
Massive demand for its COVID-19 diagnostic services as well as an ever-increasing selection of other diagnostic tests.
Recs
Quest has a strong presence in laboratory diagnostics. They are a robust company relied upon by many in healthcare. It will be hard for newer companies to challenge due to their enormous size and resources.
Find the members with the highest scoring picks in DGX.
amicidelbosco (32.79) Score: +186.55
The Score Leader is the player with the highest score across all their picks in DGX.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
amicidelbosco | 32.79 | 7/9/2009 |
![]() |
3W | $45.40 | +179.06% | +365.61% | +186.55 | 0 Comment | |
rtaliano | < 20 | 12/23/2009 |
![]() |
1Y | $50.40 | +151.38% | +267.40% | +116.03 | 1 Comment | |
PurePwnage | 98.57 | 11/27/2009 |
![]() |
5Y | $47.71 | +165.53% | +279.60% | +114.08 | 0 Comment | |
DiamondDawg | 88.76 | 11/25/2009 |
![]() |
5Y | $48.46 | +161.43% | +270.14% | +108.71 | 0 Comment | |
charmatica | 48.49 |
|
![]() |
3Y | $37.22 | +240.39% | +336.19% | +95.80 | 0 Comment | |
EliteMerchant | 86.04 | 9/29/2008 |
![]() |
5Y | $40.65 | +211.65% | +273.58% | +61.93 | 0 Comment | |
Dividends500 | 85.32 |
|
![]() |
5Y | $44.12 | +187.12% | +128.99% | +58.13 | 1 Comment | |
snowden352 | < 20 | 6/29/2011 |
![]() |
5Y | $48.68 | +160.23% | +214.92% | +54.69 | 0 Comment | |
line70day | 42.52 | 2/28/2014 |
![]() |
1Y | $45.93 | +175.82% | +121.18% | +54.63 | 1 Comment | |
Zergum | < 20 | 3/3/2014 |
![]() |
5Y | $45.77 | +176.81% | +122.80% | +54.01 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.